Home/Pipeline/ZYH11

ZYH11

Not specified

IND filedHistorical reference

Key Facts

Indication

Not specified

Phase

IND filed

Status

Historical reference

Company

Zydus Cadila

About Zydus Cadila

A global, fully integrated pharmaceutical company developing and manufacturing generic medicines, small molecules, biologics, and vaccines across multiple therapeutic areas.

View full company profile

Therapeutic Areas

Oncology Cardiovascular Infectious Disease Dermatology Neurology Immunology

Other Not specified Drugs

Drug	Company	Phase	Status
FL116	Forlong Biotechnology	Not specified	Pipeline
FL117	Forlong Biotechnology	Not specified	Pipeline
FL118	Forlong Biotechnology	Not specified	Pipeline
FL301	Forlong Biotechnology	Not specified	Pipeline
JSKN016	AlphaMab Oncology	Phase 1	Active
JSKN033	AlphaMab Oncology	Phase 1	Active
JSKN022	AlphaMab Oncology	Phase 1	Active
JSKN027	AlphaMab Oncology	Phase 1	Active
KN019	AlphaMab Oncology	Phase 1	Active
New TCM Formulations	China SXT Pharmaceuticals	Research / Pre-clinical	Development
Long-acting Leronlimab	CytoDyn	Preclinical	Phase in progress
SR2162	SIMR (Australia) Biotech	IND Approved	Approved